Evidence map›Paper›PMID 19801670›Full record

ArticleThe Journal of biological chemistry2009

Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.

Kenichiro Araki, Tatsuo Shimura, Toshiki Yajima, Soichi Tsutsumi, Hideki Suzuki, Kohji Okada, Tsutomu Kobayashi, Avraham Raz, Hiroyuki Kuwano

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Current and future trials of targeted therapies in cutaneous melanoma.Advances in experimental medicine and biology · 2013
    Review
  17. Article
  18. Glucose metabolism gene variants modulate the risk of pancreatic cancer.Cancer prevention research (Philadelphia, Pa.) · 2011
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Kenichiro ArakiDepartment of General Surgical Science (Surgery I), Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, Japan. karaki@showa.gunma-u.ac.jp
Tatsuo Shimura
Toshiki Yajima
Soichi Tsutsumi
Hideki Suzuki
Kohji Okada
Tsutomu Kobayashi
Avraham Raz
Hiroyuki Kuwano
Gunma University · JPThe Barbara Ann Karmanos Cancer Institute · US

Funding

MOTILITY FACTOR RECEPTORR01CA051714 · NCI · WAYNE STATE UNIVERSITY · PI RAZ, AVRAHAM · 1991 to 2012
$3.8M
NCI NIH HHS R01 CA051714
6 · The paper itself

Abstract

It is well known that phosphoglucose isomerase/autocrine motility factor (AMF) promotes cell migration in an autocrine manner in various tumor cells. However, it remains unclear whether certain cytokines modulate the effects of AMF on tumor cell migration. Because interleukin (IL)-8, a proinflammatory cytokine, is produced by melanoma cells and has been correlated with melanoma migration, the migratory ability of melanoma cells induced by AMF may also involve induction of IL-8 expression. In the present study, we assessed whether AMF promotes melanoma cell migration through autocrine production of IL-8. We found that AMF stimulation increased IL-8 production through up-regulation of IL-8 mRNA transcription, especially in biologically early stage melanoma cells. AMF-induced migration of these cells was inhibited by a specific neutralizing antibody against IL-8. The IL-8 production induced by AMF was mediated by the ERK1/2 pathways. These findings suggest that melanoma migration induced by AMF is mediated by autocrine production of IL-8 as a novel downstream modulator of the AMF signaling pathway.

Indexed as

Gene Expression Regulation, NeoplasticCell Line, TumorCell MovementCell ProliferationExtracellular Signal-Regulated MAP KinasesGlucose-6-Phosphate IsomeraseHumansInterleukin-8MelanomaModels, Biologicalp38 Mitogen-Activated Protein KinasesPhosphorylationSignal TransductionSkin NeoplasmsExtracellular Signal-Regulated MAP KinasesGlucose-6-Phosphate IsomeraseInterleukin-8p38 Mitogen-Activated Protein Kinases

Identifiers

PMID19801670
PMCPMC2781644
OpenAlexW2014703687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.